What is Clinical Research?

Clinical Research involves the thorough testing of therapeutic medicines and medical devices in progressive steps called phases. This allows researchers to ask and answer questions in a way that ensures reliable information is obtained about the medicine being investigated whilst protecting patient safety.

Clinical trials are undertaken to determine if new treatments are safe and effective and should be approved for use. Clinical trials can also be focused on discovering new ways of using existing treatments.

Why is Clinical Research important?

Research helps us to improve treatment options and care of people with different medical conditions. It helps us establish important information about different treatments and to improve treatment effectiveness while developing medicines with fewer side-effects.

New treatments can only be made available if benefits are demonstrated in a clinical trial. A clinical trial is one of the final stages of a long and rigorous research process. Studies are undertaken with patients to find out whether promising approaches to disease prevention and treatments are the best they can be.

In Australia and New Zealand

Boehringer Ingelheim works closely with leading General Practitioners and Specialists in clinical settings and hospitals throughout Australia and New Zealand. From small, focussed studies to large-scale research involving thousands of patients, our local research data contributes to Boehringer Ingelheim's global Clinical Research Programs aimed at ensuring our medicines are the best they can be for patients around the world.

Commited to improving the health of patients

Boehringer Ingelheim is commited to improving the health of patients and undertakes research programs locally to enable patients in Australia and New Zealand access to new therapies and treatments sooner. Thorough local data is preferable when presenting products for registration and reimbursement on the Australian and New Zealand market.

Our Clinical Research in Australia and New Zealand primarily consists of Phase ll, Phase lll, and Phase lV clinical trials.

Our areas of research

Currently, we are conducting research in the following therapeutic areas:

  • Cardiovascular (e.g deep vein thrombosis, stroke prevention)
  • Oncology (e.g lung, breast, ovarian and colorectal cancer)
  • Metabolism (e.g diabetes mellitus type ll)
  • Respiratory (e.g chronic obstructive pulmonary disease, asthma, idiopathic pulmonary fibrosis)
  • Immunology (e.g rheumatoid arthritis, crohn's disease)